
There’s a whole lot of explaining to do before many U.S. patients and doctors will feel comfortable with biosimilars in …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

